We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+20.49%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$1.73B
AUM Growth
+$225M
Cap. Flow
+$22.1M
Cap. Flow %
1.27%
Top 10 Hldgs %
47.96%
Holding
98
New
32
Increased
17
Reduced
16
Closed
27

Top Buys

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$41.6M
2
WSM icon
Williams-Sonoma
WSM
+$31.1M
3
DECK icon
Deckers Outdoor
DECK
+$29.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$28.6M
5
AZO icon
AutoZone
AZO
+$28.5M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$50.8M
2
ENR icon
Energizer
ENR
+$34.9M
3
FL
Foot Locker
FL
+$26.5M
4
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
+$26.5M
5
TGT icon
Target
TGT
+$25.7M

Sector Composition

Rank Sector Weight
1 Healthcare 45.34%
2 Miscellaneous 28.01%
3 Consumer Discretionary 17.1%
4 Consumer Staples 5.85%
5 Technology 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAIN icon
76
CALL
Hain Celestial
HAIN
$62.1M
– –
-17,000
Closed -$36.5M
LOW icon
77
Lowe's Companies
LOW
$113B
– –
-116,000
Closed -$12.8M
TGT icon
78
Target
TGT
$73.8B
– –
-240,000
Closed -$25.7M
TSCO icon
79
Tractor Supply
TSCO
$18.3B
– –
-540,000
Closed -$9.77M
ULTA icon
80
Ulta Beauty
ULTA
$23.6B
– –
-46,500
Closed -$11.7M
UNH icon
81
UnitedHealth
UNH
$361B
– –
-88,000
Closed -$19.1M
URBN icon
82
Urban Outfitters
URBN
$6.87B
– –
-170,000
Closed -$4.78M
VFC icon
83
VF Corp
VFC
$5.21B
– –
-285,000
Closed -$25.4M
WEN icon
84
Wendy's
WEN
$1.45B
– –
-1,000,000
Closed -$20M
WING icon
85
Wingstop
WING
$2.96B
– –
-148,000
Closed -$12.9M
CSCI
86
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
– –
-4,800
Closed -$494K
DYNT
87
DELISTED
Dynatronics Corp
DYNT
– –
-107,200
Closed -$1.31M
CGRN
88
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
– –
-83,500
Closed -$2.67M
BLCM
89
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-103,496
Closed -$1.09M
CLVS
90
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-20,000
Closed -$7.86M
ATRS
91
DELISTED
Antares Pharma, Inc.
ATRS
– –
-5,624,000
Closed -$18.8M
VLRX
92
DELISTED
VALERITAS HOLDINGS INC
VLRX
– –
-1,060,000
Closed -$1.52M
DPLO
93
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
– –
-5,400,000
Closed -$26.5M
BLPH
94
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
– –
-59,000
Closed -$427K
BOLD
95
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-636,000
Closed -$17.9M
ONCE
96
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-250,000
Closed -$24.2M
SPHS
97
DELISTED
Sophiris Bio, Inc.
SPHS
– –
-1,793,666
Closed -$2.21M
CELG
98
DELISTED
Celgene Corp
CELG
– –
-512,000
Closed -$50.8M
1 2 3
4

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Armistice Capital held 98 positions worth $1.73B, up 15% from $1.51B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Armistice Capital's Q4 2019 filing shows 32 new, 17 increased, 16 reduced and 27 closed positions. Its largest new stake was Supernus Pharmaceuticals: 1,712,000 shares worth $40.6M. The largest sale was Celgene Corp, an estimated $50.8M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 42% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

  • Armistice Capital's largest Q4 2019 buy was Supernus Pharmaceuticals: 1,712,000 shares worth $40.6M.
  • Armistice Capital added most to PTC Therapeutics in Q4 2019, an estimated $26.4M increase.
  • Armistice Capital's biggest Q4 2019 reduction was Kraft Heinz, cutting an estimated $24.5M.
  • Armistice Capital fully exited Celgene Corp in Q4 2019, selling an estimated $50.8M.
  • Armistice Capital's ten largest holdings make up 48% of its $1.73B portfolio in Q4 2019.
  • Armistice Capital opened 32 new positions and closed 27 in Q4 2019.
  • Armistice Capital's portfolio value rose 15% quarter-over-quarter to $1.73B.

Based on Armistice Capital's 13F filing for Q4 2019, filed 14 Feb 2020.